Close linkage of a hypervariable DNA probe on chromosome 4q (pH30, locus D4S139) has been found with the locus for facioscapulohumeral disease. Three recombinants were identified in a total of 140 meioses, giving a maximum lod score of 36-77 at a recombination fraction of 0-02. All but two of the families studied proved informative with this probe; all informative families showed evidence of linkage (except one family with a single scorable meiosis), making genetic heterogeneity unlikely from our data. The close linkage and highly informative nature of the probe will make it suitable for clinical application in presymptomatic and prenatal diagnosis. We have also confirmed loose linkage with the marker (Mfd22, locus D4S171) used to establish the initial assignment of the disorder to chromosome 4.
is often delayed until the second or third decades or even later. 4 The condition is progressive, and although between 10 to 20% of those affected become severely disabled by middle The data for linkage between the two marker loci given in table 1 show a maximum recombination fraction of 0 16 at a lod score of 3-01 and with wide confidence intervals (0-08 to 0-29). Table 2 gives the data for D4S139 and FSHD separately by family. Only three crossovers were found in a total of 140 scorable meioses; two occurred in families showing evidence of linkage (families 035 and 087) and one was the single scorable meiosis in family 028, so that our data provide no evidence for genetic heterogeneity. The individual pedigrees are shown in the figure together with genotype data for pH30.
The recombinant event noted in family 028 was in a 15 year old subject whose affected status was questionable, but was scored as 'affected' by the empirical criteria. The recombinant subject in family 087 was also young (14 years) but was undoubtedly 'affected', albeit mildly. In family 035 the recombinant subject was scored as 'unaffected' at the age of 18 years, and again on reassessment at 22 HRASI   INT2  DIIS24  D1S84  ETSI  PAH  F8VWF  A2M  COL2AI  D13S5  IGHGI  GM  D15SI  D15S2  HBAI  APRT   D17S71  D17S36   D18S3  D18S7  D18S8   D18S1I   APOC2  D19S9  PKCG  D2OS5  D20S6  D21SII  IGLV The precise localisation of the FSHD gene on chromosome 4q is currently under study, as is its relationship to other genetic markers in the region. These markers include the DNA probe EFD139,26 the factor XI gene (FII),27 and the autosomal breakpoint of the X;4 translocation found in a patient with Duchenne muscular dystrophy.28 Study of the relationship of FSHD to these and further loci should determine flanking markers for the disorder and should also contribute to our understanding of the detailed map of this region of chromosome 4.
There are currently no obvious candidate genes for FSHD known on the basis of either its chromosomal localisation or the nature of the neuromuscular defect; the autosomal dystrophin locus has been conclusively excluded by the results described above. However, the accurate localisation that now exists for FSHD will make the assessment of future candidate genes feasible and will also allow the techniques of physical mapping to be applied to the characterisation of a well defined and relatively restricted chromosomal region.
Finally, the existence of close and continuing collaboration between the groups involved in research on FSHD, something that has already proved of great value in the initial localisation of the gene, should be of even greater help in subsequent steps towards isolation of the gene itself.
